BioSpace News Archive

Amplyx Pharmaceuticals, a biotech company dedicated to developing innovative therapies for debilitating and life-threatening diseases in patients with compromised immune systems, announced today that two independent review committees completed their planned safety and efficacy assessment of data from 50% of the planned study population enrolled in the Company’s Phase 2 open-label clinical trial of fosmanogepix (APX001) for the treatment of candidemia.

BioLife Solutions, Inc. (NASDAQ: BLFS), a leading developer and supplier of a portfolio of best in class bioproduction tools for cell and gene therapies, today announced several new customers have adopted the evo cold chain management system in clinical trials targeting cancer and other leading causes of death.

Benitec Biopharma (ASX: BLT, NASDAQ: BNTC), today announced their plans to complete three non-clinical studies that will facilitate the filing of an Investigational New Drug (IND) application and the formal initiation of a Phase I clinical trial in patients suffering from Oculopharyngeal Muscular Dystrophy (OPMD).

Actinium Pharmaceuticals, Inc. (NYSE AMERICAN: ATNM) (“Actinium”) today announced that it will present at the Sachs 19th Annual Biotech in Europe Forum for Global Partnering & Investment.

Cresco Labs Inc. (“Cresco Labs” or the “Company”) (CSE: CL) (OTCQX: CRLBF), one of the largest vertically integrated multistate cannabis operators in the United States, today announced a significant expansion of its presence in Nevada and Arizona through the signing of a purchase agreement to acquire certain assets (the “Transaction”) from Tryke Companies, LLC

$1.86 Million Over Two Years to Develop Device for Isolating Exosomes

Canadian Breast Cancer Network and Self Care Catalysts announce strategic partnership, collaborating on expanding Breast Cancer literacy through a patient engagement, health tracking platform and real-world evidence research. [16-September-2019] OTTAWA, Canada and TORONTO , Sept. 16 2019 /PRNewswire/ -- Canadian Breast Cancer Network and Self Care Catalysts are plea

Results presented at ASTRO Annual Meeting evaluate clinical utility of 18F-fluciclovine PET/CT imaging in men with recurrent prostate cancer

Event proceeds will benefit DDF’s mission to raise awareness and advance funding for stomach cancer.

A small, handheld drug free device, ClearUP uses microcurrent technology that works with the body’s natural electrical system and is available for purchase now at www.tivichealth.com, on Amazon September 30